loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 206137 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL (5)

filter

01 PAR PHARM INC (5)

filter

01 TABLET;ORAL (5)

filter

01 EQ 10MG BASE;12.5MG;40MG (1)

02 EQ 10MG BASE;25MG;40MG (1)

03 EQ 5MG BASE;12.5MG;20MG (1)

04 EQ 5MG BASE;12.5MG;40MG (1)

05 EQ 5MG BASE;25MG;40MG (1)

filter

01 USA (5)

URL Supplier Web Content
TABLET;ORAL
EQ 5MG BASE;12.5MG;40M...
OLMESARTAN MEDOXOMIL, ...
USA
206137
2016-10-26
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
EQ 10MG BASE;25MG;40MG
OLMESARTAN MEDOXOMIL, ...
USA
206137
2016-10-26
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
EQ 5MG BASE;25MG;40MG
OLMESARTAN MEDOXOMIL, ...
USA
206137
2016-10-26
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
EQ 5MG BASE;12.5MG;20M...
OLMESARTAN MEDOXOMIL, ...
USA
206137
2016-10-26
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
EQ 10MG BASE;12.5MG;40...
OLMESARTAN MEDOXOMIL, ...
USA
206137
2016-10-26
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 206137

Looking for CTD TGA MCC DOSSIER APPLICATION 206137 5

19

Par Pharmaceutical, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL, with a corresponding application number 206137 and regulatory information .

proudly manufactured in the

approval since 2016-10-26

Par Pharmaceutical's OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET;ORAL, medication with EQ 5MG BASE;12.5MG;40MG of AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL.

18

Par Pharmaceutical, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL, with a corresponding application number 206137 and regulatory information .

proudly manufactured in the

approval since 2016-10-26

Par Pharmaceutical's OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET;ORAL, medication with EQ 10MG BASE;25MG;40MG of AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL.

17

Par Pharmaceutical, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL, with a corresponding application number 206137 and regulatory information .

proudly manufactured in the

approval since 2016-10-26

Par Pharmaceutical's OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET;ORAL, medication with EQ 5MG BASE;25MG;40MG of AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL.

16

Par Pharmaceutical, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL, with a corresponding application number 206137 and regulatory information .

proudly manufactured in the

approval since 2016-10-26

Par Pharmaceutical's OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET;ORAL, medication with EQ 5MG BASE;12.5MG;20MG of AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL.

15

Par Pharmaceutical, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL, with a corresponding application number 206137 and regulatory information .

proudly manufactured in the

approval since 2016-10-26

Par Pharmaceutical's OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET;ORAL, medication with EQ 10MG BASE;12.5MG;40MG of AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL.

Post Enquiry
POST ENQUIRY